Scientists in Berlin have pioneered a new "carbon ion therapy" which will fire carbon ions at 73% of the speed of light for the extremely precise treatment of inoperable tumors. »»»
SAN ANTONIO -- Researchers in San Francisco say they have found a way to predict which patients with pre-cancerous breast tumors are destined to develop cancer, potentially saving tens of thousands... »»»
An American Cancer Society study finds breast cancer patients who lack insurance, who come from areas with lower education levels, who are African American, or who are older are less likely to get a... »»»
AMSTERDAM, The Netherlands -- New Lancet Oncology publication provides important insights on the use of MammaPrint(R) Breast Cancer Prognosis Test in clinical practice New research demonstrates that... »»»
SAN ANTONIO -- A gene test can help doctors determine which breast cancer patients are likely to benefit from chemotherapy, even for those whose tumors are relatively more advanced, researchers... »»»
SAN ANTONIO -- Interim results of the Phase II XeNA (Xeloda in NeoAdjuvant) trial suggest that the combination of oral Xeloda(R) (capecitabine) and Taxotere(R) (docetaxel), with the addition of... »»»
People who undergo nonmyeloablative stem-cell transplants, or "mini transplants," for leukemia, lymphoma and other blood cancers have comparable outcomes regardless of whether they receive... »»»
Kelli Cundith didn't expect to find anything. She was 30 years old, after all. It was the first time Cundith had done a self-exam. But the lump in her breast was unmistakable. »»»
SAN ANTONIO -- Anastrozole is more effective than tamoxifen at preventing breast cancer recurrence for periods of at least 10 years in women with hormone-responsive cancers. »»»
CHICAGO -- Doctors reading mammograms miss an average of 2 in every 10 cases of breast cancer, even for women with lumps and other symptoms, researchers reported Tuesday. »»»
ST. LOUIS -- Nurses who are exposed to high levels of chemicals and drugs on the job are more likely to report having asthma, miscarriages and some cancers, according to a survey released Tuesday. »»»
GENEVA, SWITZERLAND -- Anavex Life Sciences Corp. today announced that ANAVEX 7-1037 has been shown to kill human HCT116 colon cancer cells in advanced pre-clinical studies. »»»